William Justin Carter, MD | |
1514 Jefferson Highway, New Orleans, LA 70121 | |
(504) 842-4000 | |
Not Available |
Full Name | William Justin Carter |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 19 Years |
Location | 1514 Jefferson Highway, New Orleans, Louisiana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1942404454 | NPI | - | NPPES |
04424251 | Medicaid | MS | |
1182265 | Medicaid | LA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208M00000X | Hospitalist | MD.202350 (Louisiana) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Ochsner Clinic Foundation | New orleans, LA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Ochsner Clinic Llc | 8224933619 | 2403 |
Belle Chasse Physician Services Llc | 9335379379 | 207 |
News Archive
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration seeking approval to market Colesevelam HCI 625 mg tablets.
Obesity now accounts for almost 21 percent of U.S. health care costs - more than twice the previous estimates, reports a new Cornell University study.
A Korean research team from KAIST developed a computational framework, DeepDDI, that accurately predicts and generates 86 types of drug-drug and drug-food interactions as outputs of human-readable sentences, which allows in-depth understanding of the drug-drug and drug-food interactions.
Australian regenerative medicine company, Mesoblast Limited, today announced that based on positive results from its bone marrow transplant clinical trial conducted at the University of Texas MD Anderson Cancer Center, a formal meeting has been scheduled with the United States Food and Drug Administration to discuss a proposed Phase 3 clinical trial program.
The Joseph Assignment Global Initiative, in cooperation with New Faith Baptist Church International will send lifesaving medical items to its teams in Liberia and Sierra Leone to assist doctors on the front line fighting to contain Ebola in West Africa.
› Verified 3 days ago
Entity Name | Ochsner Clinic Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1538151428 PECOS PAC ID: 8224933619 Enrollment ID: O20031126000513 |
News Archive
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration seeking approval to market Colesevelam HCI 625 mg tablets.
Obesity now accounts for almost 21 percent of U.S. health care costs - more than twice the previous estimates, reports a new Cornell University study.
A Korean research team from KAIST developed a computational framework, DeepDDI, that accurately predicts and generates 86 types of drug-drug and drug-food interactions as outputs of human-readable sentences, which allows in-depth understanding of the drug-drug and drug-food interactions.
Australian regenerative medicine company, Mesoblast Limited, today announced that based on positive results from its bone marrow transplant clinical trial conducted at the University of Texas MD Anderson Cancer Center, a formal meeting has been scheduled with the United States Food and Drug Administration to discuss a proposed Phase 3 clinical trial program.
The Joseph Assignment Global Initiative, in cooperation with New Faith Baptist Church International will send lifesaving medical items to its teams in Liberia and Sierra Leone to assist doctors on the front line fighting to contain Ebola in West Africa.
› Verified 3 days ago
Entity Name | Belle Chasse Physician Services Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1245653237 PECOS PAC ID: 9335379379 Enrollment ID: O20140313000496 |
News Archive
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration seeking approval to market Colesevelam HCI 625 mg tablets.
Obesity now accounts for almost 21 percent of U.S. health care costs - more than twice the previous estimates, reports a new Cornell University study.
A Korean research team from KAIST developed a computational framework, DeepDDI, that accurately predicts and generates 86 types of drug-drug and drug-food interactions as outputs of human-readable sentences, which allows in-depth understanding of the drug-drug and drug-food interactions.
Australian regenerative medicine company, Mesoblast Limited, today announced that based on positive results from its bone marrow transplant clinical trial conducted at the University of Texas MD Anderson Cancer Center, a formal meeting has been scheduled with the United States Food and Drug Administration to discuss a proposed Phase 3 clinical trial program.
The Joseph Assignment Global Initiative, in cooperation with New Faith Baptist Church International will send lifesaving medical items to its teams in Liberia and Sierra Leone to assist doctors on the front line fighting to contain Ebola in West Africa.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
William Justin Carter, MD 1514 Jefferson Highway, New Orleans, LA 70121 Ph: (504) 842-4000 | William Justin Carter, MD 1514 Jefferson Highway, New Orleans, LA 70121 Ph: (504) 842-4000 |
News Archive
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration seeking approval to market Colesevelam HCI 625 mg tablets.
Obesity now accounts for almost 21 percent of U.S. health care costs - more than twice the previous estimates, reports a new Cornell University study.
A Korean research team from KAIST developed a computational framework, DeepDDI, that accurately predicts and generates 86 types of drug-drug and drug-food interactions as outputs of human-readable sentences, which allows in-depth understanding of the drug-drug and drug-food interactions.
Australian regenerative medicine company, Mesoblast Limited, today announced that based on positive results from its bone marrow transplant clinical trial conducted at the University of Texas MD Anderson Cancer Center, a formal meeting has been scheduled with the United States Food and Drug Administration to discuss a proposed Phase 3 clinical trial program.
The Joseph Assignment Global Initiative, in cooperation with New Faith Baptist Church International will send lifesaving medical items to its teams in Liberia and Sierra Leone to assist doctors on the front line fighting to contain Ebola in West Africa.
› Verified 3 days ago
Dr. Brian Thomas Halbert, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 1514 Jefferson Hwy, New Orleans, LA 70121 Phone: 504-842-3910 Fax: 504-842-4533 | |
Dr. Diane Davis Van Gerwen, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1514 Jefferson Hwy, New Orleans, LA 70121 Phone: 504-842-7518 | |
Robert Lawrence Marier, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1514 Jefferson Hwy, New Orleans, LA 70121 Phone: 504-842-4000 | |
Corey Gregg, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2000 Canal St, New Orleans, LA 70112 Phone: 954-551-1683 | |
Dr. Marianne Maumus, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1514 Jefferson Hwy, New Orleans, LA 70121 Phone: 504-842-4000 | |
Dr. Ryan Stephen Kissee, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1430 Tulane Ave, Sl 50, New Orleans, LA 70112 Phone: 504-988-7809 Fax: 504-988-3971 | |
Jordan Callender, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1542 Tulane Ave, Room 436, New Orleans, LA 70112 Phone: 504-568-7884 |